[go: up one dir, main page]

FR2784580B1 - Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci - Google Patents

Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci

Info

Publication number
FR2784580B1
FR2784580B1 FR9813019A FR9813019A FR2784580B1 FR 2784580 B1 FR2784580 B1 FR 2784580B1 FR 9813019 A FR9813019 A FR 9813019A FR 9813019 A FR9813019 A FR 9813019A FR 2784580 B1 FR2784580 B1 FR 2784580B1
Authority
FR
France
Prior art keywords
microspheres
polyvinyl
making
methods
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9813019A
Other languages
English (en)
Other versions
FR2784580A1 (fr
Inventor
Egisto Boschetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosepra Inc
Original Assignee
Biosepra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33462605&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2784580(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biosepra Inc filed Critical Biosepra Inc
Priority to FR9813019A priority Critical patent/FR2784580B1/fr
Priority to PCT/EP1999/007846 priority patent/WO2000023054A1/fr
Priority to JP2000576829A priority patent/JP4467799B2/ja
Priority to ES99953858T priority patent/ES2219072T3/es
Priority to US09/419,114 priority patent/US6680046B1/en
Priority to AT99953858T priority patent/ATE262319T1/de
Priority to CA002345205A priority patent/CA2345205A1/fr
Priority to DE69915858T priority patent/DE69915858T2/de
Priority to AU10396/00A priority patent/AU1039600A/en
Priority to EP99953858A priority patent/EP1128816B1/fr
Publication of FR2784580A1 publication Critical patent/FR2784580A1/fr
Priority to US10/692,785 priority patent/US7591993B2/en
Publication of FR2784580B1 publication Critical patent/FR2784580B1/fr
Application granted granted Critical
Priority to US12/348,867 priority patent/US7670592B2/en
Priority to US12/686,320 priority patent/US8673266B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9813019A 1998-10-16 1998-10-16 Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci Expired - Fee Related FR2784580B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9813019A FR2784580B1 (fr) 1998-10-16 1998-10-16 Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
DE69915858T DE69915858T2 (de) 1998-10-16 1999-10-15 Mikrosphären aus polyvinylalkohol sowie verfahren zu deren herstellung
EP99953858A EP1128816B1 (fr) 1998-10-16 1999-10-15 Microspheres de poly(alcool de vinyle) et procedes de fabrication de celles-ci
JP2000576829A JP4467799B2 (ja) 1998-10-16 1999-10-15 ポリビニルアルコール微小球、ならびにその製造方法および治療用途
ES99953858T ES2219072T3 (es) 1998-10-16 1999-10-15 Microesferas de poli(alcohol vinilico) y metodos para su preparacion.
US09/419,114 US6680046B1 (en) 1998-10-16 1999-10-15 Method of embolization using polyvinyl alcohol microspheres
AT99953858T ATE262319T1 (de) 1998-10-16 1999-10-15 Mikrosphären aus polyvinylalkohol sowie verfahren zu deren herstellung
CA002345205A CA2345205A1 (fr) 1998-10-16 1999-10-15 Microspheres de poly(alcool de vinyle), procedes de fabrication et applications de celles-ci
PCT/EP1999/007846 WO2000023054A1 (fr) 1998-10-16 1999-10-15 Microspheres de poly(alcool de vinyle), procedes de fabrication et applications de celles-ci
AU10396/00A AU1039600A (en) 1998-10-16 1999-10-15 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same
US10/692,785 US7591993B2 (en) 1998-10-16 2003-10-27 Polyvinyl alcohol microspheres, and injectable solutions of the same
US12/348,867 US7670592B2 (en) 1998-10-16 2009-01-05 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
US12/686,320 US8673266B2 (en) 1998-10-16 2010-01-12 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9813019A FR2784580B1 (fr) 1998-10-16 1998-10-16 Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci

Publications (2)

Publication Number Publication Date
FR2784580A1 FR2784580A1 (fr) 2000-04-21
FR2784580B1 true FR2784580B1 (fr) 2004-06-25

Family

ID=33462605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9813019A Expired - Fee Related FR2784580B1 (fr) 1998-10-16 1998-10-16 Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci

Country Status (10)

Country Link
US (4) US6680046B1 (fr)
EP (1) EP1128816B1 (fr)
JP (1) JP4467799B2 (fr)
AT (1) ATE262319T1 (fr)
AU (1) AU1039600A (fr)
CA (1) CA2345205A1 (fr)
DE (1) DE69915858T2 (fr)
ES (1) ES2219072T3 (fr)
FR (1) FR2784580B1 (fr)
WO (1) WO2000023054A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8226926B2 (en) 2005-05-09 2012-07-24 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents
US8697137B2 (en) 2000-03-24 2014-04-15 Biosphere Medical, Inc. Methods of using microspheres for active embolization

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
FR2784580B1 (fr) 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
ES2295021T3 (es) * 1999-03-25 2008-04-16 Metabolix, Inc. Utilizacion y aplicaciones medicas de polimeros de poli(hidroxialcanoatos).
WO2001066016A1 (fr) * 2000-03-06 2001-09-13 Scimed Life Systems, Inc. Agents emboliques visibles par ultrasons
CA2402773C (fr) 2000-03-13 2011-10-11 Biocure, Inc. Compositions de revetement et de gonflement des tissus
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
WO2001068720A1 (fr) * 2000-03-13 2001-09-20 Biocure, Inc. Compositions anti-embolie
AU2001249221A1 (en) 2000-03-20 2001-10-03 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
US20040266983A1 (en) * 2000-08-17 2004-12-30 Reeve Lorraine E Purified polyoxyalkylene block copolymers
US9080146B2 (en) * 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
IL160799A0 (en) 2001-09-12 2004-08-31 Virexx Medical Corp Vascular occlusion solid-phase agent with immobilised platelet binding agent
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) * 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
EP1511522B1 (fr) * 2002-06-12 2011-08-10 Boston Scientific Limited Agents gonflants
US20080226723A1 (en) * 2002-07-05 2008-09-18 Celonova Biosciences, Inc. Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en) * 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) * 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
AU2003285905A1 (en) * 2002-11-04 2004-06-07 Biosphere Medical, Inc. Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same
ES2298724T3 (es) * 2003-02-21 2008-05-16 Biocompatibles Uk Limited Suministro de un ains a partir de agentes embolicos.
AU2004224439B2 (en) * 2003-03-24 2010-07-15 Genzyme Corporation Temporary embolization using inverse thermosensitive polymers
JP2004313759A (ja) * 2003-03-31 2004-11-11 Toray Ind Inc 血管塞栓材料
DK1638615T3 (en) 2003-05-08 2015-01-12 Tepha Inc MEDICAL POLYHYDROXYALKANOATE TEXTILES AND FIBERS
JP2007528853A (ja) * 2003-07-08 2007-10-18 テファ, インコーポレイテッド 徐放性薬物送達のためのポリ−4−ヒドロキシブチレートマトリックス
JP2007503221A (ja) * 2003-08-22 2007-02-22 テファ, インコーポレイテッド ポリヒドロキシアルカノエート神経再生デバイス
WO2005018600A2 (fr) * 2003-08-22 2005-03-03 Cube Medical A/S Méthode de traitement d'un patient atteint d'une tumeur solide
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7700086B2 (en) * 2003-11-06 2010-04-20 Pluromed, Inc. Internal clamp for surgical procedures
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050238870A1 (en) * 2004-04-22 2005-10-27 Marcia Buiser Embolization
JP4655505B2 (ja) * 2004-04-28 2011-03-23 東レ株式会社 架橋生分解性粒子およびその製造方法
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
JP4857268B2 (ja) 2004-06-29 2012-01-18 バイオキュア・インコーポレーテッド 脊椎椎間板髄核移植片
DK1778305T3 (da) * 2004-08-03 2010-10-18 Tepha Inc Ikke-krøllende polyhydroxyalkanoatsuturer
WO2006013309A1 (fr) * 2004-08-03 2006-02-09 Biocompatibles Uk Limited Rélargage de médicaments à partir des agents emboliques
WO2006013376A2 (fr) * 2004-08-04 2006-02-09 Biocompatibles Uk Limited Liberation de medicaments a partir d'agents emboliques
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9107850B2 (en) * 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
WO2006046155A2 (fr) 2004-10-25 2006-05-04 Polyzenix Gmbh Particules polymeres chargeables pour des applications therapeutiques et/ou diagnostiques et methodes de preparation et d'utilisation de ces particules
US8663225B2 (en) * 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) * 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) * 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) * 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
EP1900381A4 (fr) * 2005-07-01 2012-01-11 Nippon Synthetic Chem Ind Particules de pva destinées à être utilisées lors de l'embolisation temporaire d'un vaisseau sanguin, procédé pour la production de celles-ci et agent d'embolisation temporaire pour un vaisseau sanguin
US20070083219A1 (en) * 2005-10-12 2007-04-12 Buiser Marcia S Embolic coil introducer sheath locking mechanisms
US8007509B2 (en) * 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
JP2009513265A (ja) * 2005-10-26 2009-04-02 バイオキュア・インコーポレーテッド 膨潤可能な物品を有するヒドロゲル椎間板移植片
US8152839B2 (en) * 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US20070142859A1 (en) * 2005-12-19 2007-06-21 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) * 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US20070142560A1 (en) * 2005-12-21 2007-06-21 Young-Ho Song Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
ES2554527T3 (es) * 2006-01-24 2015-12-21 Biocompatibles Uk Limited Proceso para rellenar partículas poliméricas con un fármaco
US20080033366A1 (en) * 2006-01-30 2008-02-07 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
EP1986706B1 (fr) * 2006-01-30 2011-08-17 Biosphere Medical, Inc. Particules d'embolisation intravasculaires poreuses et leurs procédés de fabrication
US8252339B2 (en) 2006-04-11 2012-08-28 Massachusetts Institute Of Technology Medical treatment applications of swellable and deformable microspheres
US7838035B2 (en) 2006-04-11 2010-11-23 E. I. Du Pont De Nemours And Company Microsphere powder of high density, swellable, deformable, durable occlusion-forming microspheres
US8062673B2 (en) 2006-04-11 2011-11-22 E I Du Pont De Nemours And Company Process for embolization using swellable and deformable microspheres
US7794755B2 (en) 2006-04-11 2010-09-14 E.I. Du Pont De Nemours And Company Process for preparation of swellable and deformable microspheres
US20070299461A1 (en) * 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
WO2008014065A1 (fr) * 2006-07-27 2008-01-31 Boston Scientific Limited Particules
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US20080145658A1 (en) * 2006-12-15 2008-06-19 Boston Scientific Scimed, Inc. Freeze Thaw Methods For Making Polymer Particles
WO2009046281A2 (fr) * 2007-10-05 2009-04-09 Boston Scientific Scimed, Inc. Particules injectables
US20090111763A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable polymeric particles for bone augmentation and methods of preparing and using the same
US20090110738A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
US20090110731A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
US20090110730A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
US8114436B2 (en) * 2008-03-25 2012-02-14 Boston Scientific Scimed, Inc. Compositions and methods for delivery of embolics
CN102143996A (zh) * 2008-10-30 2011-08-03 大卫·刘 微球形多孔可生物相容支架及制造该支架的方法和装置
EP2626088B1 (fr) 2009-10-06 2014-12-03 Regents of the University of Minnesota Microsphères biorésorbables pour embolisation
WO2011057131A1 (fr) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Hydrogels à base de polysaccharide
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
GB201008843D0 (en) * 2010-05-27 2010-07-14 Aubin Ltd Method and composition
US9232805B2 (en) 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
CN101885852B (zh) * 2010-07-07 2012-01-11 天津大学 表面光滑明胶微球与制备方法
CN103124762B (zh) * 2010-09-29 2016-03-16 塞恩心血管公司 制备微球的方法及其制备的微球和微球的用途
EP2646000B1 (fr) 2010-11-29 2015-04-29 Centre Hospitalier Universitaire Vaudois Composition pour l'embolie chemique comprenant des agents anti angiogenetic
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
IT1404015B1 (it) * 2011-02-04 2013-11-08 Hsd Holding Smart Device S R L Uso di un polimero di destrano reticolato come filtro contro l'inalazione di sostanze nocive per la salute
CN102492178B (zh) * 2011-11-29 2014-12-24 中国科学院过程工程研究所 一种尺寸均一的魔芋葡甘聚糖微球及其制备方法
US9351993B2 (en) 2012-06-14 2016-05-31 Microvention, Inc. Polymeric treatment compositions
KR102275634B1 (ko) 2012-10-15 2021-07-08 마이크로벤션, 인코포레이티드 폴리머 치료 조성물
US8936795B2 (en) 2012-12-19 2015-01-20 Regents Of The University Of Minnesota Liquid embolic material including carboxymethyl chitosan crosslinked with carboxymethyl cellulose
JP6373961B2 (ja) 2013-03-13 2018-08-15 バイオスフィア メディカル,インコーポレイテッド ラジオアイソトープ結合微粒子の組成物及び結合方法
GB2519738A (en) * 2013-09-06 2015-05-06 Biocompatibles Uk Ltd Radiopaque polymers
KR102505172B1 (ko) 2013-09-19 2023-02-28 마이크로벤션, 인코포레이티드 중합체 필름
AU2014321277B2 (en) 2013-09-19 2017-07-20 Terumo Corporation Polymer particles
WO2015070094A1 (fr) 2013-11-08 2015-05-14 Microvention, Inc. Particules polymères
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
EP4591894A3 (fr) 2014-12-11 2025-08-27 Tepha, Inc. Procédés d'orientation de fil multifilament et monofilaments de poly-4-hydroxybutyrate et copolymères correspondants
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
US10071181B1 (en) 2015-04-17 2018-09-11 Teleflex Innovations S.À.R.L. Resorbable embolization spheres
ES2795010T3 (es) * 2015-06-19 2020-11-20 Sillajen Inc Composiciones y métodos para la embolización viral
CN105148327B (zh) * 2015-07-29 2019-07-12 广东博与再生医学有限公司 一种多糖-聚乙烯醇栓塞微球的制备方法
US10182979B2 (en) 2016-03-22 2019-01-22 Regents Of The University Of Minnesota Biodegradable microspheres
CN109153968A (zh) * 2016-04-12 2019-01-04 联合细胞Ev股份公司 从生物流体样品中分离细胞外囊泡(ev)
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
KR102162370B1 (ko) 2016-09-28 2020-10-06 테루모 가부시키가이샤 중합체 입자
WO2018070894A1 (fr) * 2016-10-12 2018-04-19 Общество С Ограниченной Ответственностью "Технология Лекарств" Particules pour la chimioembolisation. procédé de production et d'utilisation de ceux-ci
CN111200976B (zh) 2017-10-09 2023-07-07 微仙美国有限公司 放射性液体栓塞
CN108744020A (zh) * 2018-06-12 2018-11-06 杭州艾力康医药科技有限公司 一种离子交换型聚乙烯醇微球的制备方法
JP7410871B2 (ja) 2018-11-21 2024-01-10 株式会社クラレ 単分散性ハイドロゲル粒子
CA3164746A1 (fr) * 2019-06-19 2020-12-24 Zylo Therapeutics, Inc. Monolithes fonctionnalises par du soufre et particules derivees de ceux-ci en tant que transporteur d'oxyde nitrique pour des applications pharmaceutiques et cosmetiques
KR20220141824A (ko) * 2020-02-18 2022-10-20 닛산 가가쿠 가부시키가이샤 액정 나노캡슐 및 그 제조 방법, 그리고 해당 액정 나노캡슐을 갖는 액정 나노캡슐 분산액 및 액정 표시 소자
CN114159554B (zh) * 2021-11-22 2022-12-13 广州优理氏生物科技有限公司 一种纤连蛋白-聚乙烯醇微球的制备方法及其应用
CN114642640B (zh) * 2022-05-23 2022-09-16 杭州旸顺医疗科技有限公司 微球及其制备方法、制备系统
WO2024176915A1 (fr) 2023-02-22 2024-08-29 株式会社クラレ Article formant un hydrogel sec, hydrogel et procédé de production d'un article formant un hydrogel sec
WO2024182477A2 (fr) * 2023-02-28 2024-09-06 Medstar Health, Inc. Inhibiteurs de l'angiogenèse couplés à des microparticules emboliques
CN116159178B (zh) * 2023-04-18 2023-07-04 上海汇禾医疗器械有限公司 一种小粒径栓塞微球及其制备方法

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US499188A (en) * 1893-06-06 Territory
US3919411A (en) 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
JPS49108168A (fr) 1973-02-16 1974-10-15
JPS49108158A (fr) 1973-02-19 1974-10-15
JPS5350290A (en) 1976-10-18 1978-05-08 Sumitomo Chem Co Ltd Preparation f hydrogel
DE2935712A1 (de) 1978-09-07 1980-03-20 Sumitomo Chemical Co Verfahren zum herstellen von stark absorbierenden polymerisaten
US4314032A (en) 1978-10-26 1982-02-02 Kureha Kagaku Kogyo Kabushiki Kaisha Crosslinked polyvinyl alcohol gel
US4268495A (en) 1979-01-08 1981-05-19 Ethicon, Inc. Injectable embolization and occlusion solution
US4306031A (en) 1979-08-14 1981-12-15 Mitsubishi Chemical Industries Limited Weakly acidic cation exchange resin and process for producing same
GB2088392B (en) 1980-12-03 1984-05-02 Sumitomo Chemical Co Production of hydrogels
JPS57128709A (en) 1981-02-03 1982-08-10 Sumitomo Chem Co Ltd Preparation of hydrogel
CA1225585A (fr) 1983-06-30 1987-08-18 Maria T. Litvinova Composition pour l'embolisation des vaisseaux sanguins
GB8418772D0 (en) 1984-07-24 1984-08-30 Geistlich Soehne Ag Chemical substances
US5186922A (en) 1985-03-15 1993-02-16 See/Shell Biotechnology, Inc. Use of biodegradable microspheres labeled with imaging energy constrast materials
US4680171A (en) 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
EP0229165A4 (fr) 1985-07-02 1988-07-25 Target Therapeutics Inc Procede et composition de collagene vaso-occlusifs.
US4803075A (en) 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
JPS6317904A (ja) 1986-07-09 1988-01-25 Mitsubishi Chem Ind Ltd 多孔質架橋ポリビニルアルコ−ル粒子の製造法
CA1329800C (fr) * 1987-12-29 1994-05-24 Hiroaki Takayanagi Agent composite de separation
GB8813425D0 (en) 1988-06-07 1988-07-13 Hall L D Magnetic resonance imaging
JPH064713B2 (ja) 1988-07-22 1994-01-19 テルモ株式会社 生体適合性材料
JPH0286838A (ja) 1988-09-22 1990-03-27 Terumo Corp 水不溶性ヒドロゲルおよびその製造方法
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5258028A (en) 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5092883A (en) 1988-12-28 1992-03-03 Eppley Barry L Method for promoting soft connective tissue growth and repair in mammals
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5007940A (en) 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
DE69114782T2 (de) 1990-08-08 1996-04-18 Takeda Chemical Industries Ltd Intravaskulär embolisierendes Mittel mit Gehalt an einem die Angiogenesis hemmenden Stoff.
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
AU649787B2 (en) * 1991-02-25 1994-06-02 Debiopharm S.A. Therapeutic agents for the treatment of multidrug resistance to cancers
FR2676927B1 (fr) 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
JP3356447B2 (ja) 1991-10-16 2002-12-16 テルモ株式会社 乾燥高分子ゲルからなる血管病変塞栓材料
WO1993017669A1 (fr) 1992-02-28 1993-09-16 Board Of Regents, The University Of Texas System Hydrogels biodegradables, polymerisables utilises en tant que materiaux en contact avec des tissus et excipients a liberation controlee
JPH0656676A (ja) 1992-08-05 1994-03-01 Hori Shinichi 血管塞栓用懸濁液
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
ES2215207T3 (es) 1993-03-09 2004-10-01 Baxter International Inc. Microparticulas de macromoleculas y metodos de produccion.
UA10911C2 (uk) 1994-08-10 1996-12-25 Мале Впроваджувальне Підприємство "Іhтерфалл" Біосумісhий гідрогель
US5955108A (en) 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
EP0805656B1 (fr) * 1995-01-27 2004-05-06 SciMed Life Systems, Inc. Systeme d'embolisation
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
DE19601699A1 (de) * 1996-01-18 1997-07-24 Wacker Chemie Gmbh Redispergierbare Polymerisatpulver und daraus erhältliche wäßrige Polymerisat-Dispersionen
US5785977A (en) 1996-02-07 1998-07-28 Breithbarth; Richard Non-metallic microparticle carrier materials
US5803075A (en) * 1996-03-15 1998-09-08 Yaru Llc Surgical mask with adhesive strip to improve breathing
US5925683A (en) * 1996-10-17 1999-07-20 Target Therapeutics, Inc. Liquid embolic agents
US6139963A (en) * 1996-11-28 2000-10-31 Kuraray Co., Ltd. Polyvinyl alcohol hydrogel and process for producing the same
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
WO1999012577A1 (fr) * 1997-09-05 1999-03-18 Nycomed Imaging As Particules polymeres en alcool polyvinylique comprenant un agent de contraste destine a la chimio-embolisation
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
ATE283709T1 (de) 1998-03-06 2004-12-15 Biosepra Medical Inc Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
FR2784580B1 (fr) * 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
US6710126B1 (en) 1999-11-15 2004-03-23 Bio Cure, Inc. Degradable poly(vinyl alcohol) hydrogels
KR100335866B1 (ko) * 2000-01-06 2002-05-10 박호군 폴리아세트산비닐 코어/폴리비닐알코올 외피의 2중 구조를갖는 미세구형 색전재료 및 그의 제조방법
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
WO2001068720A1 (fr) 2000-03-13 2001-09-20 Biocure, Inc. Compositions anti-embolie
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
AU2001249221A1 (en) 2000-03-20 2001-10-03 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US7338657B2 (en) 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP2286799B1 (fr) 2000-03-24 2015-07-29 Biosphere Medical, Inc. Microsphères pour embolisation active
US20030212022A1 (en) 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
US6537569B2 (en) 2001-02-14 2003-03-25 Microvention, Inc. Radiation cross-linked hydrogels
WO2002100444A1 (fr) 2001-06-08 2002-12-19 Biosphere Medical Inc. Microparticules marquees a l'aide d'un metal colloidal, production et utilisation de celles-ci
US6488952B1 (en) 2001-08-28 2002-12-03 John P. Kennedy Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
US6911219B2 (en) 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
EP2484344B1 (fr) 2005-05-09 2016-02-10 Biosphere Medical, S.A. Compositions et procédés pour utiliser des microsphères et des agents de contraste non ioniques
EP1986706B1 (fr) 2006-01-30 2011-08-17 Biosphere Medical, Inc. Particules d'embolisation intravasculaires poreuses et leurs procédés de fabrication
US20080033366A1 (en) 2006-01-30 2008-02-07 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697137B2 (en) 2000-03-24 2014-04-15 Biosphere Medical, Inc. Methods of using microspheres for active embolization
US8741351B2 (en) 2000-03-24 2014-06-03 Biosphere Medical, Inc. Microspheres for active embolization
US8226926B2 (en) 2005-05-09 2012-07-24 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents
US8709384B2 (en) 2005-05-09 2014-04-29 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents
US9040022B2 (en) 2005-05-09 2015-05-26 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents

Also Published As

Publication number Publication date
US6680046B1 (en) 2004-01-20
DE69915858T2 (de) 2005-03-03
FR2784580A1 (fr) 2000-04-21
DE69915858D1 (de) 2004-04-29
JP4467799B2 (ja) 2010-05-26
EP1128816B1 (fr) 2004-03-24
ES2219072T3 (es) 2004-11-16
US20100119572A1 (en) 2010-05-13
WO2000023054A1 (fr) 2000-04-27
EP1128816A1 (fr) 2001-09-05
CA2345205A1 (fr) 2000-04-27
US7670592B2 (en) 2010-03-02
US20090117196A1 (en) 2009-05-07
JP2002527206A (ja) 2002-08-27
US7591993B2 (en) 2009-09-22
ATE262319T1 (de) 2004-04-15
AU1039600A (en) 2000-05-08
US8673266B2 (en) 2014-03-18
US20040091425A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
FR2784580B1 (fr) Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
DE69623550D1 (de) Verfahren zur Herstellung von Graphitfasern
NO971645D0 (no) Fremgangsmåte for fremstilling av derivater av 4a,5,9,10,11,12,-heksahydro-6H-benzofuro(3a,3,2-ef)(2)-benzacepin
DE69502689D1 (de) Verfahren zur Herstellung von Polarisierendem Glas
DE69104461D1 (de) Verfahren zur Erzeugung von hochreinem Wasserstoff.
HUP9800091A2 (hu) Enzimatikusan aktív rekombináns karboxipeptidáz-B előállítása
DE69407653D1 (de) Verfahren zur Herstellung von Wasserstoffsuperoxyd
ATE268749T1 (de) Verfahren zur herstellung von iopamidol
IT9083313A1 (it) Processo per la produzione di perossido di idrogeno (ii)
HU205550B (en) Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
ATE361334T1 (de) Verfahren zur herstellung von hochreinem polycarbonat
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
ATE293632T1 (de) Verfahren zur herstellung von alkylverbrückten ligandsystemen und übergangsmetallverbindungen
DE59608635D1 (de) Neues verfahren zur herstellung von nucleosiden
FI935831L (fi) Prosessi vetyperoksidin tuottamiseksi
DE69605064D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid
ATE219087T1 (de) Verfahren zur herstellung von diisopinocampheylchloroboran
DE50003988D1 (de) Verfahren für die Herstellung von opakem Quarzglas und nach dem Verfahren hergestelltes opakes Bauteil
DE69707901D1 (de) Verfahren zur herstellung von kontrastmitteln
FR2714054B1 (fr) Procédé de fabrication de la 4-hydroxy-5-méthyl-3[2H]-furanone et utilisations de cette dernière.
ATE116309T1 (de) Verfahren zur herstellung von dodecahydro- 3a,6,6,9a-tetramethylnaphtho(2,1b>furan und von haloethyldecalin-derivaten.
DE69531207D1 (de) Verfahren zur Herstellung von körnigen Reinigungsmitteln
DE68916022D1 (de) Verfahren zur herstellung von wasserstoffgas.
DE60107189D1 (de) Verfahren zur Herstellung von wasserfreien Mirtazapin-Kristallen.
ATE425143T1 (de) Verfahren zur herstellung von indolen

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
ST Notification of lapse

Effective date: 20140630